FDA recall D-0437-2017

Roxane Laboratories, Inc. · Class II · drug

Product

Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.

Reason for recall

Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2016-12-22
Report date
2017-02-01
Termination date
2017-12-18
Voluntary/Mandated
Voluntary: Firm initiated
Location
Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0437-2017